ORLANDO, FL (UroToday.com) - Due to its relative low incidence, there is a paucity of literature regarding the use of adjuvant chemotherapy in the management of upper tract urothelial carcinoma (UTUC) and few clinical trials have addressed chemotherapy in this high risk population.
Your session will expire in 8 hours requiring you to log in each day to view content.